KALAMAZOO, Mich., Nov. 23 /PRNewswire-FirstCall/ -- Stryker Corporation announced today that it will participate in the following investor conferences:
December 1, 2005 -- 11:30 a.m. Eastern Time and 2:15 p.m. Eastern Time Merrill Lynch Med Tech Fundamentals Conference New York, New York December 8, 2005 -- 9:00 a.m. Eastern Time Harris Nesbitt Healthcare Conference New York, New York
Simultaneous webcasts of the Company’s presentations will be available on Stryker’s website at http://www.stryker.com via the For Investors page. The Merrill Lynch Conference presentation will be archived on Stryker’s website for 14 days. The Harris Nesbitt Conference presentation will be archived for 6 months.
Certain statements made in the presentations may constitute forward- looking statements. They will be based upon management’s current expectations and will be subject to various risks and uncertainties that could cause the Company’s actual results to differ materially from those expressed or implied in such statements. In addition to factors that may be discussed in these presentations, such factors include, but are not limited to: changes in current interpretations of the American Jobs Creation Act, regulatory actions, including cost-containment measures, that could adversely affect the price of or demand for the Company’s products; unanticipated issues arising in connection with clinical studies and eventual United States Food and Drug Administration approval of OP-1, the FlexiCore and CerviCore spinal implant products or other new product introductions; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; changes in economic conditions that adversely affect the level of demand for the Company’s products; changes in foreign exchange markets; changes in financial markets; and changes in the competitive environment. Additional information concerning these and other factors are contained in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
Stryker Corporation is one of the world’s leading medical device companies with the most broadly-based range of products in orthopaedics and a significant presence in other medical specialties. The Company’s products include implants that are used in joint replacement, trauma, craniomaxillofacial and spine surgeries; orthobiologics; operating room and interventional pain products; surgical navigation, endoscopic, communications and digital imaging systems; as well as patient handling and emergency medical equipment. In addition, Stryker provides outpatient physical therapy services in the United States.
Stryker Corporation
CONTACT: Dean H. Bergy, Vice President and Chief Financial Officer ofStryker Corporation, +1-269-385-2600
Web site: http://www.stryker.com/
